Multiple sclerosis (MS) is one of the very difficult diseases to treat; it has also shown high resistance to the normal MS treating drugs. In a progressive state the disease causes physical disabilities by affecting both the brain and spinal cord. However, there is great hope for such patients with the newly stem plant research results released earlier this month.

The results cover a five year term where 24 volunteer patients of ages 26 to 52 with relapsing-remitting multiple sclerosis (MS). First a sample of their blood forming stem cells was collected and was later administered back after they received a high dosage of chemotherapy to supress their immunity. The research shows that a one-time treatment with high-dose immunosuppressive therapy (HDIT) followed by autologous hematopoietic cell transplant (HCT) is more effective than a continuous treatment with drugs for a specific MS. In the research the patients received the (HDIT/MS) but never took any MS medication later. After the five year trial period, 69 percent of the patients shown no new brain lesions, progression of disability and relapse of MS symptoms. Some of the patients showed improvement through the recovery of some of the physical abilities that they had lost earlier. Even so, the National Institute of Allergy and Infectious Diseases sponsored research resulted in two fatalities none of which was related to the research.

Dr. Shiva Gopal Vasishta; a New Jersey based neurologist and Psychiatrist is among the people who are working tirelessly to cure such neurological illness. He graduated in 1979 from Government medical college, completed his neurological residency both at Boston City Hospital and Tufts Medical Center. He has worked in the field for almost forty years and is currently practicing at Eastern Neurodiagnostic Associates. Dr. Shiva also has affiliations with Kennedy University Hospital meaning that he can not only treat but also admit his patients to the hospital.

Dr. Shiva’ practice not only uses English but supports Spanish in order to cover a wider scope of patients. Dr. Shiva is truly a noble man whose main objective is to ensure that patients receive the best quality patient care.